CDK6 and breast carcinoma: Overall, we inferred that breast cancer with low p21 expression largely depends on the CDK2–cyclin E complex to progress to the S-phase; thus, CDK4 and CDK6–cyclin D complex are no longer necessary to overcome the G1–S checkpoint (Figure 7C and 7D).